What is osteosarcoma?

Osteosarcoma (OSA) is the most common primary malignant bone tumour in dogs β€” accounting for 85% of all bone tumours. It is a highly aggressive cancer with a strong tendency to metastasise, primarily to the lungs. It predominantly affects large and giant breeds, most commonly in the long bones of the limbs.

Risk factors and breeds

Signs

Diagnosis

Treatment options

Amputation + chemotherapy (gold standard)

Amputation removes the primary tumour and eliminates the pain focus. Post-operative chemotherapy (carboplatin or cisplatin-based protocols) delays metastasis. Median survival with amputation + chemo: 10–12 months. 20–25% of dogs survive beyond 2 years.

Limb-sparing surgery

In selected cases, bone segment replacement (prosthesis or bone graft) preserving the limb. Higher complexity, more complications, but comparable outcomes to amputation in specialised hands.

Palliative radiation therapy

For pain control when surgery is not possible or declined. Does not cure but can meaningfully improve quality of life for months.

Palliative medical management only

Chemotherapy without surgery: median survival 4–5 months. Palliative care only (NSAIDs, pain management): 1–3 months.

Life quality after amputation

Dogs adapt remarkably well to three limbs. Recovery is often rapid, particularly in younger animals in good overall condition. Most owners are surprised by how well their tripawd copes β€” and how quickly quality of life returns.